CCHFV-GP38 Breadth: Mouse Survival Data for Vaccine Candidates

26.1 KB of survival data supports a study on a Crimean-Congo hemorrhagic fever virus protein. The dataset compares outcomes for mice vaccinated with rGP38 versus rVSV, with some groups receiving monoclonal antibody treatment. Authored by Kartik Chandran and last updated on 2026-05-15, it is shared under a CC-BY-4.0 license.

Use Cases

• Compare survival outcomes based on the rGP38 vaccination regimen described.
• Analyze the effect of monoclonal antibody dose (1.5 mg vs. 0.1 mg MAR1-5A3) on survival mentioned in the description.
• Benchmark vaccine candidate efficacy using the rVSV vaccination group as a reference point.

Strengths

• Data is directly associated with a published scientific paper, providing clear research context.
• Shared under a permissive CC-BY-4.0 license for reuse.
• File size of 26.1 KB indicates a focused, manageable dataset.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset's 26.1 KB size suggests a very limited scope, likely containing only summary-level results.

Provenance

Source

figshare

Collection Method

Likely generated from laboratory experiments described in the associated paper.

Freshness

Last updated 2026-05-15 19:28:59; freshness should be verified.